RU2157847C2 - Молекула днк для экспрессии, стимулируемой солями желчи липазы (bssl) - Google Patents
Молекула днк для экспрессии, стимулируемой солями желчи липазы (bssl) Download PDFInfo
- Publication number
- RU2157847C2 RU2157847C2 RU97117367/13A RU97117367A RU2157847C2 RU 2157847 C2 RU2157847 C2 RU 2157847C2 RU 97117367/13 A RU97117367/13 A RU 97117367/13A RU 97117367 A RU97117367 A RU 97117367A RU 2157847 C2 RU2157847 C2 RU 2157847C2
- Authority
- RU
- Russia
- Prior art keywords
- bssl
- parc
- polypeptide
- dna molecule
- seq
- Prior art date
Links
- 108020004414 DNA Proteins 0.000 title claims abstract description 25
- 102000053602 DNA Human genes 0.000 title claims abstract description 15
- 108010087173 bile salt-stimulated lipase Proteins 0.000 title description 71
- 102100035687 Bile salt-activated lipase Human genes 0.000 title description 60
- 241000235058 Komagataella pastoris Species 0.000 claims abstract description 38
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 30
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 25
- 229920001184 polypeptide Polymers 0.000 claims abstract description 24
- 108010076504 Protein Sorting Signals Proteins 0.000 claims abstract description 21
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 15
- 239000013612 plasmid Substances 0.000 claims abstract description 11
- 239000013600 plasmid vector Substances 0.000 claims abstract description 8
- 230000028327 secretion Effects 0.000 claims abstract description 4
- 238000012258 culturing Methods 0.000 claims abstract description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 5
- 150000001413 amino acids Chemical class 0.000 claims description 18
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 15
- 101100244726 Pisum sativum PPF-1 gene Proteins 0.000 claims description 12
- 108010025188 Alcohol oxidase Proteins 0.000 claims description 10
- 108091026890 Coding region Proteins 0.000 claims description 10
- 101000715643 Homo sapiens Bile salt-activated lipase Proteins 0.000 claims description 10
- 102000052905 human CEL Human genes 0.000 claims description 10
- 108010051210 beta-Fructofuranosidase Proteins 0.000 claims description 6
- 239000001963 growth medium Substances 0.000 claims description 6
- 239000001573 invertase Substances 0.000 claims description 5
- 235000011073 invertase Nutrition 0.000 claims description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 33
- 230000000694 effects Effects 0.000 abstract description 20
- 108090001060 Lipase Proteins 0.000 abstract description 12
- 102000004882 Lipase Human genes 0.000 abstract description 12
- 239000004367 Lipase Substances 0.000 abstract description 12
- 235000019421 lipase Nutrition 0.000 abstract description 12
- 239000013598 vector Substances 0.000 abstract description 10
- 239000003833 bile salt Substances 0.000 abstract description 5
- 229940093761 bile salts Drugs 0.000 abstract description 5
- 230000001413 cellular effect Effects 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 238000010353 genetic engineering Methods 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 description 38
- 235000018102 proteins Nutrition 0.000 description 30
- 102000004169 proteins and genes Human genes 0.000 description 30
- 239000012228 culture supernatant Substances 0.000 description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 14
- 238000001262 western blot Methods 0.000 description 14
- 239000002299 complementary DNA Substances 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 12
- 239000012634 fragment Substances 0.000 description 12
- 239000013604 expression vector Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 9
- 108020003589 5' Untranslated Regions Proteins 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 230000006698 induction Effects 0.000 description 7
- 108020005345 3' Untranslated Regions Proteins 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000004927 fusion Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 101150005709 ARG4 gene Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 101150069554 HIS4 gene Proteins 0.000 description 5
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 5
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 125000001475 halogen functional group Chemical group 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 241000235648 Pichia Species 0.000 description 3
- 101100004044 Vigna radiata var. radiata AUX22B gene Proteins 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 230000013595 glycosylation Effects 0.000 description 3
- 238000006206 glycosylation reaction Methods 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- FQVLRGLGWNWPSS-BXBUPLCLSA-N (4r,7s,10s,13s,16r)-16-acetamido-13-(1h-imidazol-5-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide Chemical compound N1C(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CC1=CN=CN1 FQVLRGLGWNWPSS-BXBUPLCLSA-N 0.000 description 2
- UEJJHQNACJXSKW-UHFFFAOYSA-N 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C1CCC(=O)NC1=O UEJJHQNACJXSKW-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 102100034035 Alcohol dehydrogenase 1A Human genes 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 101150015280 Cel gene Proteins 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 101000892220 Geobacillus thermodenitrificans (strain NG80-2) Long-chain-alcohol dehydrogenase 1 Proteins 0.000 description 2
- 101000780443 Homo sapiens Alcohol dehydrogenase 1A Proteins 0.000 description 2
- 241001506991 Komagataella phaffii GS115 Species 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 102100033639 Acetylcholinesterase Human genes 0.000 description 1
- 108010022752 Acetylcholinesterase Proteins 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- 108010023063 Bacto-peptone Proteins 0.000 description 1
- 241000588807 Bordetella Species 0.000 description 1
- 241000701822 Bovine papillomavirus Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102100036806 Carboxylesterase 5A Human genes 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282575 Gorilla Species 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101001018100 Homo sapiens Lysozyme C Proteins 0.000 description 1
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 101150051118 PTM1 gene Proteins 0.000 description 1
- 101150003479 Parg gene Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 101150014136 SUC2 gene Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940022698 acetylcholinesterase Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 229960004405 aprotinin Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 102000035122 glycosylated proteins Human genes 0.000 description 1
- 108091005608 glycosylated proteins Proteins 0.000 description 1
- 102000057041 human TNF Human genes 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 108010021711 pertactin Proteins 0.000 description 1
- 108010085336 phosphoribosyl-AMP cyclohydrolase Proteins 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 230000003234 polygenic effect Effects 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 239000012465 retentate Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN351/MAS/95 | 1995-03-23 | ||
| SE9501939A SE9501939D0 (sv) | 1995-05-24 | 1995-05-24 | DNA molecules for expression of polypeptides |
| SE9501939-4 | 1995-05-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU97117367A RU97117367A (ru) | 1999-07-10 |
| RU2157847C2 true RU2157847C2 (ru) | 2000-10-20 |
Family
ID=20398427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU97117367/13A RU2157847C2 (ru) | 1995-05-24 | 1996-03-12 | Молекула днк для экспрессии, стимулируемой солями желчи липазы (bssl) |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0832257A1 (cs) |
| JP (1) | JP2000510683A (cs) |
| KR (1) | KR19980703238A (cs) |
| CN (1) | CN1185812A (cs) |
| AU (1) | AU5165696A (cs) |
| CZ (1) | CZ297397A3 (cs) |
| EE (1) | EE9700321A (cs) |
| HU (1) | HUP9802388A3 (cs) |
| IL (1) | IL118335A0 (cs) |
| PL (1) | PL322848A1 (cs) |
| RU (1) | RU2157847C2 (cs) |
| SE (1) | SE9501939D0 (cs) |
| TR (1) | TR199701010T1 (cs) |
| TW (1) | TW434314B (cs) |
| WO (1) | WO1996037622A1 (cs) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2697218C1 (ru) * | 2018-07-11 | 2019-08-13 | федеральное государственное автономное образовательное учреждение высшего образования "Московский физико-технический институт (национальный исследовательский университет)" | Использование сигнальных пептидов митохондриальной локализации для увеличения уровня гетерологической экспрессии белков в P.pastoris и S.cerevisiae |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001255501A1 (en) * | 2000-04-21 | 2001-11-07 | Monsanto Technology Llc | Blood-pressure reducing polypeptides containing vpp derived from microorganisms |
| KR100717353B1 (ko) * | 2006-04-12 | 2007-05-11 | 한국생명공학연구원 | 피키아 파스토리스 유래의 자동 유도성 ｎｐｓ 프로모터 및이를 이용한 이종 단백질의 제조방법 |
| CN103952386A (zh) * | 2014-03-31 | 2014-07-30 | 四川农业大学 | 利用毕赤酵母高效分泌表达重组猪胰腺脂肪酶ppl的方法 |
| CA3146193A1 (en) * | 2019-07-12 | 2021-01-21 | Lipum Ab | Novel bssl antibodies |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0443063A1 (en) * | 1990-02-22 | 1991-08-28 | Henkel Research Corporation | Pseudomonas lipase gene, vectors for the expression thereof, production of the lipase by transformed microorganisms and uses of this enzyme |
| DE4111321A1 (de) * | 1990-04-14 | 1991-10-17 | Kali Chemie Ag | Alkalische bacillus-lipasen, hierfuer codierende dna-sequenzen sowie bacilli, die diese lipasen produzieren |
| US5200183A (en) * | 1987-11-19 | 1993-04-06 | Oklahoma Medical Research Foundation | Recombinant bile salt activated lipases |
| US5306636A (en) * | 1990-10-31 | 1994-04-26 | Kurita Water Industries Ltd. | Gene, vector and transformant for thermostable lipase and preparation of them and thermostable lipase |
| RU2060275C1 (ru) * | 1988-09-26 | 1996-05-20 | Лябофина С.А. | Способ получения человеческого лизоцима |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0438200B1 (en) * | 1990-01-16 | 2002-07-17 | Centro De Ingenieria Genetica Y Biotecnologia | Method for the expression of heterologous genes in the yeast Pichia pastoris, expression vectors and transformed microorganisms |
| IS4130A (is) * | 1993-03-01 | 1994-09-02 | Ab Astra | Ný fjölpeptíð |
-
1995
- 1995-05-24 SE SE9501939A patent/SE9501939D0/xx unknown
-
1996
- 1996-03-12 EP EP96908415A patent/EP0832257A1/en not_active Withdrawn
- 1996-03-12 HU HU9802388A patent/HUP9802388A3/hu unknown
- 1996-03-12 WO PCT/SE1996/000318 patent/WO1996037622A1/en not_active Ceased
- 1996-03-12 CZ CZ972973A patent/CZ297397A3/cs unknown
- 1996-03-12 KR KR1019970706642A patent/KR19980703238A/ko not_active Ceased
- 1996-03-12 RU RU97117367/13A patent/RU2157847C2/ru not_active IP Right Cessation
- 1996-03-12 JP JP08535592A patent/JP2000510683A/ja not_active Abandoned
- 1996-03-12 AU AU51656/96A patent/AU5165696A/en not_active Abandoned
- 1996-03-12 PL PL96322848A patent/PL322848A1/xx unknown
- 1996-03-12 CN CN96194083A patent/CN1185812A/zh active Pending
- 1996-03-12 EE EE9700321A patent/EE9700321A/xx unknown
- 1996-03-12 TR TR97/01010T patent/TR199701010T1/xx unknown
- 1996-04-10 TW TW085104253A patent/TW434314B/zh active
- 1996-05-20 IL IL11833596A patent/IL118335A0/xx unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5200183A (en) * | 1987-11-19 | 1993-04-06 | Oklahoma Medical Research Foundation | Recombinant bile salt activated lipases |
| RU2060275C1 (ru) * | 1988-09-26 | 1996-05-20 | Лябофина С.А. | Способ получения человеческого лизоцима |
| EP0443063A1 (en) * | 1990-02-22 | 1991-08-28 | Henkel Research Corporation | Pseudomonas lipase gene, vectors for the expression thereof, production of the lipase by transformed microorganisms and uses of this enzyme |
| DE4111321A1 (de) * | 1990-04-14 | 1991-10-17 | Kali Chemie Ag | Alkalische bacillus-lipasen, hierfuer codierende dna-sequenzen sowie bacilli, die diese lipasen produzieren |
| US5306636A (en) * | 1990-10-31 | 1994-04-26 | Kurita Water Industries Ltd. | Gene, vector and transformant for thermostable lipase and preparation of them and thermostable lipase |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2697218C1 (ru) * | 2018-07-11 | 2019-08-13 | федеральное государственное автономное образовательное учреждение высшего образования "Московский физико-технический институт (национальный исследовательский университет)" | Использование сигнальных пептидов митохондриальной локализации для увеличения уровня гетерологической экспрессии белков в P.pastoris и S.cerevisiae |
Also Published As
| Publication number | Publication date |
|---|---|
| EE9700321A (et) | 1998-06-15 |
| CN1185812A (zh) | 1998-06-24 |
| CZ297397A3 (cs) | 1998-03-18 |
| HUP9802388A2 (hu) | 1999-02-01 |
| TW434314B (en) | 2001-05-16 |
| HUP9802388A3 (en) | 2000-10-30 |
| JP2000510683A (ja) | 2000-08-22 |
| SE9501939D0 (sv) | 1995-05-24 |
| TR199701010T1 (xx) | 1998-01-21 |
| IL118335A0 (en) | 1996-09-12 |
| PL322848A1 (en) | 1998-02-16 |
| EP0832257A1 (en) | 1998-04-01 |
| WO1996037622A1 (en) | 1996-11-28 |
| KR19980703238A (ko) | 1998-10-15 |
| AU5165696A (en) | 1996-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0301670B2 (en) | Kluyveromyces as a host strain | |
| Christensen et al. | High level expression of recombinant genes in Aspergillus oryzae | |
| US6602682B1 (en) | Kluyveromyces as a host strain | |
| KR0184693B1 (ko) | 재조합 사람 락토페린 생산방법 | |
| KR0181179B1 (ko) | 피치아 파스토리스 산성 인산효소 유전자의 디앤에이 단편 및 이를 사용하는 방법 | |
| US20020132335A1 (en) | System for expressing hyperthermostable protein | |
| JPH04501662A (ja) | 混合給送組換え酵母発酵 | |
| HK1053145B (zh) | 一种来自yarrowia lypolytica的抗酸性细胞外脂酶的克隆和表达 | |
| US5705358A (en) | Process for producing/secreting a protein by a transformed mould using expression/secretion regulating regions derived from a aspergillus endoxylanase II gene | |
| CN100432099C (zh) | 转录因子 | |
| WO1991013971A1 (en) | Neurospora expression system | |
| RU2157847C2 (ru) | Молекула днк для экспрессии, стимулируемой солями желчи липазы (bssl) | |
| US5516679A (en) | Penicillin V amidohydrolase gene from Fusarium oxysporum | |
| Rodriguez et al. | Invertase secretion in Hansenula polymorpha under the AOX1 promoter from Pichia pastoris | |
| EP0362183A2 (en) | Process for the production of human lysozyme | |
| Phongdara et al. | Cloning and characterization of the gene encoding a repressible acid phosphatase (PHO1) from the methylotrophic yeast Hansenula polymorpha | |
| US4757020A (en) | Novel expression plasmids containing the full cDNA sequence of calf prochymosin | |
| US6025159A (en) | D-amino acid oxidase promoter from T. variabilis | |
| US20030040040A1 (en) | Dna molecules for expression of bile salt-stimulated lipase | |
| JPH06503718A (ja) | メチロトローフ酵母細胞におけるヒトリゾチムの産生とその効率的な分泌 | |
| Kajino et al. | Isolation of a protease-deficient mutant of Bacillus brevis and efficient secretion of a fungal protein disulfide isomerase by the mutant | |
| MXPA97006853A (en) | A dna molecule for expression of bile salt-stimulated lipase (bssl) | |
| JPH09505989A (ja) | 菌類からのα‐１，４‐グルカンリアーゼ、その精製、遺伝子クローニングおよび微生物での発現 | |
| JP3383341B2 (ja) | 糸状菌および酵母で使用可能なポリペプチド発現用プラスミドおよびそれを用いたポリペプチドの製造法 | |
| JPH08228779A (ja) | 組換え胆汁酸塩活性化リパーゼの高収率発現方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20050313 |